Cellromax Science
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Cellromax Science is listed on KOSDAQ and classified under Consumer Staples, Food & Beverage. Its market value is US$34.5M. In FY2025 it reported revenue of US$16.7M and operating profit of US$2.1M.
A written company profile is not available yet; the facts above come from exchange and DART data.
Cellromax Science in five facts
Where is Cellromax Science listed and in which sector?
Cellromax Science (Korean name: 셀로맥스사이언스) trades under KRX code 471820 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Consumer Staples sector, Food & Beverage.
How large is Cellromax Science?
Its market capitalisation was US$34.5M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Cellromax Science's latest annual revenue and operating profit?
For fiscal year 2025, Cellromax Science reported revenue of US$16.7M, operating profit of US$2.1M and net income of US$2.6M, per its annual report on DART (data retrieved from DART on 2026-10-02). Revenue was up 2.6% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-10-02
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Cash/in-kind dividend decision (quarterly dividend)
Cellromax Science declared a cash dividend of US$0.04 per share, equal to about 1.2% of the recent share price.
Dividend · Oct 8 - DisclosureSep 28
- DisclosureSep 10
- Cash/in-kind dividend decision (quarterly dividend)
Cellromax Science declared a cash dividend of US$0.03 per share, equal to about 1.1% of the recent share price.
Dividend · Jul 10 - Cash/in-kind dividend decision (quarterly dividend)
Cellromax Science declared a cash dividend of US$0.03 per share, equal to about 1% of the recent share price.
Dividend · Apr 20 - [Amended] Cash/in-kind dividend decision
Cellromax Science updated its declared cash dividend of US$0.03 per share, equal to about 0.9% of the recent share price.
Dividend · Apr 17 - Treasury share disposal: results reportTreasury Shares · Apr 6
- Material event report (treasury share disposal)
Cellromax Science disclosed a plan to sell treasury shares worth US$116K, about 0.4% of its market value.
Treasury Shares · Mar 13 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Cellromax Science reported consolidated results for FY2025: revenue of US$15.4M (+2.56% year on year), operating profit of US$1.95M (−48.97% year on year) and net income of US$1.85M (−30.16% year on year).
Earnings · Feb 13